Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 3
1980 2
1981 4
1982 1
1983 3
1985 2
1986 5
1987 5
1988 11
1989 12
1990 19
1991 15
1992 13
1993 24
1994 24
1995 14
1996 24
1997 26
1998 18
1999 20
2000 22
2001 31
2002 17
2003 30
2004 24
2005 27
2006 30
2007 27
2008 32
2009 35
2010 43
2011 49
2012 41
2013 46
2014 46
2015 83
2016 82
2017 97
2018 110
2019 107
2020 106
2021 124
2022 98
2023 109
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

1,517 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric acute lymphoblastic leukemia.
Inaba H, Mullighan CG. Inaba H, et al. Haematologica. 2020 Nov 1;105(11):2524-2539. doi: 10.3324/haematol.2020.247031. Haematologica. 2020. PMID: 33054110 Free PMC article. Review.
The last decade has witnessed great advances in our understanding of the genetic and biological basis of childhood acute lymphoblastic leukemia (ALL), the development of experimental models to probe mechanisms and evaluate new therapies, and the development o …
The last decade has witnessed great advances in our understanding of the genetic and biological basis of childhood acute lymphobla
International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ. Duffield AS, et al. Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24. Virchows Arch. 2023. PMID: 36422706 Free PMC article. Review.
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute lymphoblastic leukemia (T-ALL) includes both revisions to subtypes previously outlined in the 2016 WHO classifica …
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T- …
Acute lymphoblastic leukemia: a comprehensive review and 2017 update.
Terwilliger T, Abdul-Hay M. Terwilliger T, et al. Blood Cancer J. 2017 Jun 30;7(6):e577. doi: 10.1038/bcj.2017.53. Blood Cancer J. 2017. PMID: 28665419 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) is the second most common acute leukemia in adults, with an incidence of over 6500 cases per year in the United States alone. The hallmark of ALL is chromosomal abnormalities and genetic alterations involved in
Acute lymphoblastic leukemia (ALL) is the second most common acute leukemia in adults, with an incidence
BCR-ABL1-like B-Acute Lymphoblastic Leukemia/Lymphoma: A Comprehensive Review.
Jain S, Abraham A. Jain S, et al. Arch Pathol Lab Med. 2020 Feb;144(2):150-155. doi: 10.5858/arpa.2019-0194-RA. Epub 2019 Oct 23. Arch Pathol Lab Med. 2020. PMID: 31644323 Free article. Review.
.-: In the 2016 update of the World Health Organization (WHO) classification of hematopoietic neoplasms, BCR-ABL1-like B-acute lymphoblastic leukemia/lymphoma (B-ALL) is added as a new provisional entity that lacks the BCR-ABL1 translocat …
.-: In the 2016 update of the World Health Organization (WHO) classification of hematopoietic neoplasms, BCR-ABL1-like B-acute
Genetic Basis of Acute Lymphoblastic Leukemia.
Iacobucci I, Mullighan CG. Iacobucci I, et al. J Clin Oncol. 2017 Mar 20;35(9):975-983. doi: 10.1200/JCO.2016.70.7836. Epub 2017 Feb 13. J Clin Oncol. 2017. PMID: 28297628 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and despite cure rates exceeding 90% in children, it remains an important cause of morbidity and mortality in children and adults. The past decade has been marked by extraordinary advance
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and despite cure rates exceeding 90% in childre
Immunotherapy in pediatric acute lymphoblastic leukemia.
Inaba H, Pui CH. Inaba H, et al. Cancer Metastasis Rev. 2019 Dec;38(4):595-610. doi: 10.1007/s10555-019-09834-0. Cancer Metastasis Rev. 2019. PMID: 31811553 Free PMC article. Review.
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than 90% in high-income countries. ...For immunotherapy, the approval of antibody-based therapy (with blinatumomab in 2014 and inotuzumab ozogam …
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than …
Precision medicine in acute lymphoblastic leukemia.
Pui CH. Pui CH. Front Med. 2020 Dec;14(6):689-700. doi: 10.1007/s11684-020-0759-8. Epub 2020 Oct 19. Front Med. 2020. PMID: 33074527 Free PMC article. Review.
The cure rate of childhood acute lymphoblastic leukemia (ALL) has exceeded 90% in some contemporary clinical trials. ...BH3 profiling and other preclinical methods have identified several high-risk subtypes, such as hypodiplod, early T-cell precurso
The cure rate of childhood acute lymphoblastic leukemia (ALL) has exceeded 90% in some contemporary clinical trials. .. …
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia.
Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S, Kim YM. Kruse A, et al. Int J Mol Sci. 2020 Feb 5;21(3):1054. doi: 10.3390/ijms21031054. Int J Mol Sci. 2020. PMID: 32033444 Free PMC article. Review.
Minimal residual disease (MRD) refers to a chemotherapy/radiotherapy-surviving leukemia cell population that gives rise to relapse of the disease. ...
Minimal residual disease (MRD) refers to a chemotherapy/radiotherapy-surviving leukemia cell population that gives rise to rel …
Lymphoblastic Lymphoma: a Concise Review.
Intermesoli T, Weber A, Leoncin M, Frison L, Skert C, Bassan R. Intermesoli T, et al. Curr Oncol Rep. 2022 Jan;24(1):1-12. doi: 10.1007/s11912-021-01168-x. Epub 2022 Jan 20. Curr Oncol Rep. 2022. PMID: 35059993 Review.
PURPOSE OF REVIEW: Lymphoblastic lymphoma (LBL) is a rare, highly aggressive non-Hodgkin lymphoma variant virtually indistinguishable from acute lymphoblastic leukemia (ALL). ...RECENT FINDINGS: T-LBL displays a mediastinal mass with pleuro-pericardic …
PURPOSE OF REVIEW: Lymphoblastic lymphoma (LBL) is a rare, highly aggressive non-Hodgkin lymphoma variant virtually indistinguishable …
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.
Lejman M, Chałupnik A, Chilimoniuk Z, Dobosz M. Lejman M, et al. Int J Mol Sci. 2022 Mar 2;23(5):2755. doi: 10.3390/ijms23052755. Int J Mol Sci. 2022. PMID: 35269896 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) is a heterogeneous group of hematologic malignancies characterized by abnormal proliferation of immature lymphoid cells. ...
Acute lymphoblastic leukemia (ALL) is a heterogeneous group of hematologic malignancies characterized by abnormal proli
1,517 results